Efficacy of Chemotherapeutic Agents Under Hypoxic Conditions in Pulmonary Adenocarcinoma Multidrug Resistant Cell Line

References

• Semenza GL. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 2000; 35 (2): 71–103.
   PubMed Web of Science ®Google Scholar
• Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor la in common human cancers and their metastases. Cancer Res 1999; 59 (22): 5830–5835.
   PubMed Web of Science ®Google Scholar
• Dales JP, Garcia S, Meunier-Carpentier S, et al. Overexpression of hypoxia-inducible factor HIF-lalpha pre-dicts early relapse in breast cancer: Retrospective study in a series of 745 patients. Int J Cancer 2005; 116 (5): 734–739.
   PubMed Web of Science ®Google Scholar
• M Hockel, P Vaupel. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001; 93 (4): 266–276.
   PubMedGoogle Scholar
• Wykoff CC, Pugh CW, Harris AL, Maxwell PH, Ratcliffe PJ. The HIF pathway: Implications for patterns of gene expression in cancer. Novartis Found Symp 2001; 240: 212–225.
   PubMedGoogle Scholar
• Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP. Hypoxia-inducible factor-l-depen-dent regulation of the multidrug resistance (MDR1) gene.Cancer Res 2002; 62 (12): 3387–3394.
   PubMed Web of Science ®Google Scholar
• Wartenberg M, Ling FC, Muschen M, et al. Regulation of the multidrug resistance transporter P-glycoprotein in multi-cellular tumor spheroids by Hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J 2003; 17 (3): 503–505.
   PubMedGoogle Scholar
• Wartenberg M, Gronczynska S, Bekhite MM, et al. Regulation of the multidrug resistance transporter P-glycopro-tein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species. Int J Cancer 2005; 113 (2): 229–240.
   PubMed Web of Science ®Google Scholar
• Hug V, Johnston D, Finders M, Hortobagyi G. Use of growth-stimulatory hormones to improve the in vitro therapeu-tic index of doxorubicin for human breast tumors. Cancer Res 1986; 46 (1): 147.
   PubMed Web of Science ®Google Scholar
• Lee WP. The role of reduced growth rate in the devel-opment of drug resistance of HOB1 lymphoma cells to vin-cristine. Cancer Lett 1993; 73 (2-3): 105.
   PubMed Web of Science ®Google Scholar
• Valeriote F, van Putten L. Proliferation-dependent cyto-toxicity of anticancer agents: A review. Cancer Res 1975; 35 (10): 2619.
   PubMed Web of Science ®Google Scholar
• Wilson WH, Teruya-Feldstein J, Fest T, et al. Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. Blood 1997; 89 (2): 601–609.
   PubMed Web of Science ®Google Scholar
• Haq R, Zanke B. Inhibition of apoptotic signaling path-ways in cancer cells as a mechanism of chemotherapy resis-tance, Cancer Metastasis Rev 1998; 17 (2): 233-239.
   Google Scholar
• Bartussek C, Naumann U, Weller M. Accumulation of mutant p53 (V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells indepen-dent of endogenous p53 status. Exp Cell Res 1999; 253 (2): 432–439.
   PubMed Web of Science ®Google Scholar
• Liu S, Bishop WR, Liu M. Differential effects of cell cycle regulatory protein p21 (WAF1/Cipl) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat 2003; 6 (4): 183–195.
   PubMed Web of Science ®Google Scholar
• Rebbaa A, Chou PM, Mirkin BL. Factors Secreted by human neuroblastoma mediated doxorubicin resistance by acti-vating STAT3 and inhibiting apoptosis. Mol Med 2001; 7 (6): 393–400.
   PubMed Web of Science ®Google Scholar
• Krtolica A, Ludlow JW. Hypoxia arrests ovarian carci-noma cell cycle progression, but invasion is unaffected. Cancer Res 1996; 56 (5): 1168–1173.
   PubMed Web of Science ®Google Scholar
• Webster L, Hodgkiss RJ, Wilson CD. Cell cycle distribu-tion of hypoxia and progression of hypoxic tumour cells in vivo. Br J Cancer 1998; 77 (2): 227–234.
   PubMed Web of Science ®Google Scholar
• Krucher NA, Krtolica A, Lincoln J, Khan SA, Rodriguez-Rodriguez L, Ludlow JW. Mitogenic activity of steroidogenesis-inducing protein (SIP) during hypoxic stress of human ovarian carcinoma cells. Cancer Lett 1998; 133 (2): 205–214.
   PubMed Web of Science ®Google Scholar
• Zhenhong Hu, Qilin Peng, Qingquan Li. Effect of hypoxia on invasion and migration of lung carcinoma cells and its molecular basis. Chinese J Pathophysiol 2004; 20 (6): 973–975.
   Google Scholar
• Hong Huang, Zhenxiang Zhang, Yongjian Xu, Jingfang Shao. HDAC1 expression and effect of TSA on proliferation and apoptosis of A549 cells. Chinese J Cancer 2003; 22 (9): 922–926.
   Google Scholar
• Raghunand N, Gillies RJ. pH and drug resistance in tumors. Drug Resist Updat 2000; 3: 39–47.
   PubMed Web of Science ®Google Scholar
• Mahoney BP, Raghunand N, Baggett B, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in Vitro. Biochem Pharmacol 2003; 66 (7): 1207–1218.
   Google Scholar
• Gillies RJ, Deamer DW. Intracellular pH: Methods and applications. Curr Topics Bioenergetics 1978; 9: 63–87.
   Google Scholar
• Roos A. Weak Acids, weak bases, and intracellular pH. Respiration Physiology 1978; 33 (1): 27–30.
   PubMedGoogle Scholar
• Tannock IF, Rotin D. Acid pH in Tumors and its poten-tial for therapeutic exploitation. Cancer Res 1989; 49 (16): 4373–4384.
   PubMed Web of Science ®Google Scholar
• Roepe PD. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry 1992; 31 (50): 12555–12564.
   PubMed Web of Science ®Google Scholar
• Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: Potential for exploitation for the treatment of cancer. Cancer Res 1996; 56 (6): 1194–1198.
   PubMed Web of Science ®Google Scholar
• Doroshow JH. Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scav-engers and iron chelating agents. Biochem Biophys Res Commun 1986; 135 (1): 330-335.3°
   Google Scholar
• Fulda S, Susin SA, Kroemer G, Debatin KM. Molecular ordering of apoptosis induced by anticancer drugs in neurob-lastoma cells. Cancer Res 1998; 58 (19): 4453–4460.
   PubMed Web of Science ®Google Scholar
• Ravid A, Rocker D, Machlenkin A, et al.1,25-Dihydrooxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res 1999; 59 (4): 862–867.
   PubMed Web of Science ®Google Scholar
• Friesen C, Fulda S, Debatin KM. Induction of CD95 hg-and and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. Cell Death Differ 1999; 6 (5): 471–480.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Kobayashi D, Watanabe N. Augmented adri-amycin sensitivity in cells transduced with an antisense tumor necrosis factor gene is mediated by caspase-3 downstream from reactive oxygen species. Jpn J Cancer Res 2001; 92 (9): 983–988.
   PubMedGoogle Scholar
• Jie Chen, Chunxue Bai, Guishen Qian, Guijun Huang. Establishment of A549/CDDP multidrug resistant cell line. China oncology 2003; 13 (2): 186–187.
   Google Scholar
• Koch S, Mayer F, Honecker F, Schittenhelm M, Bokemeyer C. Efficacy of cytotoxic agents used in the treat-ment of testicular germ cell tumours under normoxic and hypoxic conditions in Vitro. Br J Cancer 2003; 89 (11): 2133–2139.
   PubMed Web of Science ®Google Scholar
• Greijer AE, de Jong MC, Scheffer GL, Shvarts A, van-Diest PJ, van-der-Wall E. Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells. Cell Oncol 2005; 27 (1): 43–49.
   Google Scholar
• Krishnamurthy P, Ross DD, Nakanishi T, et al. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 2004; 279 (23): 24218–24225.
   PubMed Web of Science ®Google Scholar
• Shu Xia, Yu Shiying, Xianglin Yuan, Sanpeng Xu. Effects of hypoxia on expression of P-glycoprotein and mutltidrug resistance protein in human lung adenocarcinoma A549 cell line. Natl Med J China 2004; 84 (8): 663–666.
   Google Scholar
• Raghunand N, Martinez-Zaguilan R, Wright SH, Gillies RJ. pH and drug resistance II: Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem Pharmacol 1999; 57 (9): 1047–1058.
   PubMed Web of Science ®Google Scholar
• Skvortsova I, Skvortsov S, Haidenberger A, et al. Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in Vitro. J Chemother 2004; 16 (4): 372–380.
   PubMed Web of Science ®Google Scholar
• Fardel 0, Jigorel E, Le Vee M, et al., Physiological, pharmacological and clinical features of the multidrug resis-tance protein 2. Biomed Pharmacother. 2005; 59 (3): 104-14.
   Google Scholar
• DiDonato M, Narindrasorasak S, Forbes JR, Cox DW, Sarkar B. Expression, purification, and metal binding proper-ties of the N-terminal domain from the wilson disease putative copper-transporting ATPase (ATP7B). J Biol Chem 1997; 272 (52): 33279–82.
   PubMed Web of Science ®Google Scholar
• Izquierdo MA, Scheffer GL, Flens MJ, Schroeijers AB, van-der-Valk P, Scheper RJ. Major vault protein LRP-related multidrug resistance. Eur J Cancer 1996; 32A (6): 979–984.
   Google Scholar
• Wachsberger PR, Landry J, Storck C, et al. Mammalian cells adapted to growth at pH 6.7 have elevated HSP27 levels and are resistant to cisplatin. Int J Hyperthermia 1997; 13 (3): 251-255.
   Google Scholar
• Gabr A, Kuin A, Aalders M, El-Gawly H Smets LA. Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH. Cancer Res 1997; 57 (21): 4811–6.
   Google Scholar
• Bhattacharya A, Toth K, Mazurchuk R, et al. Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with function-al magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy. Chin Cancer Res 2004; 10 (23): 8005–8017.
   Web of Science ®Google Scholar